The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term evaluation of the novel radioenhancer NBTXR3 plus radiotherapy in patients with locally advanced soft tissue sarcoma treated in the phase II/III Act.In.Sarc trial.
 
Sylvie Bonvalot
Honoraria - Nanobiotix
Research Funding - Nanobiotix (Inst)
Travel, Accommodations, Expenses - Nanobiotix
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Lilly; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Sanofi
Consulting or Advisory Role - Amgen; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Lilly; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre
 
Juliette Thariat
Honoraria - Bristol-Myers Squibb; MSD; Nanobiotix
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Nanobiotix
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Nanobiotix (Inst)
Travel, Accommodations, Expenses - Nanobiotix
 
Sebastien Carrère
Honoraria - Nanobiotix (Inst)
 
Anne Ducassou
Honoraria - Nanobiotix (Inst)
Research Funding - Nanobiotix (Inst)
 
Sunyach Marie
Honoraria - Nanobiotix (Inst)
 
Peter Agoston
Honoraria - Nanobiotix (Inst)
 
Angela M. Hong
Honoraria - Nanobiotix (Inst)
 
Augustin Mervoyer
Honoraria - Nanobiotix (Inst)
 
Marco Rastrelli
Honoraria - Nanobiotix (Inst)
 
Cecile Le Pechoux
Honoraria - Lilly (Inst); Medscape (Inst); Prime Oncology
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Nanobiotix (Inst); Roche (Inst)
 
Victor Moreno
Honoraria - Nanobiotix (Inst)
 
Rubi Khaw Li
Honoraria - Nanobiotix (Inst)
 
Béatrice Tiangco
Honoraria - Nanobiotix (Inst)
 
Zsuzsanna Papai
Honoraria - Nanobiotix (Inst)